Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President
Retrieved on:
Tuesday, October 4, 2022
Safe harbor, The O.C., GLOBE, OTC, Securities Exchange Act of 1934, Medical cannabis, DRUG, Disease, Nature, Drug Quality and Security Act, Food, Medical Marijuana, Inc., CBD, CEO, Vitis rotundifolia, FDA, Growth, CA, Brand, LLC, Safety, CNBC, SAN, Sale, Acquisition, Food and Drug Administration, Securities Act of 1933, Company, Drug, Risk management
Additionally, Bill Andreoli, the President of MFINITY Global will become the President of Medical Marijuana, Inc. subsidiary, Kannaway, LLC.
Key Points:
- Additionally, Bill Andreoli, the President of MFINITY Global will become the President of Medical Marijuana, Inc. subsidiary, Kannaway, LLC.
- MFINITY products will be marketed and sold exclusively under the Kannaway brand and are now available for sale through Kannaway independent distributors and on Kannaway.com.
- The asset purchase aligns with Medical Marijuana Inc.s newly implemented growth model of expansion via acquisition.
- Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.